ZyVersa Therapeutics Inc. and Larkspur Health Acquisition Corp. Close Business Combination; ZyVersa Expected to Begin Trading on Nasdaq December 13, 2022 (Ticker "ZVSA") ...Middle East

ZyVersa is a clinical stage biopharmaceutical company developing first-in-class product candidates for treatment of renal and inflammatory diseases WESTON, Fla. and BRIDGEWATER, N.J., Dec. 12, 2022 /PRNewswire/ -- ZyVersa Therapeutics, Inc. ("ZyVersa"), a clinical stage specialty...

Hence then, the article about zyversa therapeutics inc and larkspur health acquisition corp close business combination zyversa expected to begin trading on nasdaq december 13 2022 ticker zvsa was published today ( Tuesday 13/12/2022 - 05:16 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ZyVersa Therapeutics Inc. and Larkspur Health Acquisition Corp. Close Business Combination; ZyVersa Expected to Begin Trading on Nasdaq December 13, 2022 (Ticker "ZVSA") )

Also on site :

• Meta lines up layoffs while Microsoft offers buyouts
• Meta Prepares 8,000 Layoffs to Offset AI Infrastructure Investments .. PYMNTS.com
• China’s DeepSeek unveils latest model a year after upending global tech